Clinical Roundup Yale Cancer Center researchers identify new role for immune-boosting protein “STING” in head and neck cancer April 23, 2021Vol.47 No.16
Clinical Roundup AI could create better outcomes for bowel cancer patients April 23, 2021Vol.47 No.16
Drugs & Targets Jemperli receives FDA accelerated approval for endometrial cancer April 23, 2021Vol.47 No.16
Drugs & Targets Opdivo + chemo regimen gets FDA approval for metastatic gastric cancer, esophageal adenocarcinoma indications April 23, 2021Vol.47 No.16
Drugs & Targets Bemarituzumab receives Breakthrough Therapy designation from FDA April 23, 2021Vol.47 No.16
Drugs & Targets European Commission approves second indication of Sarclisa for relapsed multiple myeloma April 23, 2021Vol.47 No.16
Drugs & Targets NeoGenomics establishes Biomarker Assist KRAS Single Gene Testing Program for advanced NSCLC April 23, 2021Vol.47 No.16
NCI Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it” April 16, 2021Vol.47 No.15By Matthew Bin Han Ong
In Brief David Tuveson inaugurated president of AACR; Lisa Coussens is president-elect April 16, 2021Vol.47 No.15
